TNF and head and neck squamous cell carcinoma: These characteristics correlated with their resistance to treatment with birinapant alone and lesser sensitivity with the combination of the death agonists TNF-α when compared with HPV(−) HNSCC cells with FADD amplification (Fig. 4).